Man Group’s Medicines Co MDCO Stock Holding History

Man Group’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-184,508	Closed	-$15.7M	–	2026
2019 Q4	$15.7M	Buy	+184,508	New	+$12.3M	0.05%	452
2019 Q2	–	Sell	-58,673	Closed	-$1.64M	–	2091
2019 Q1	$1.64M	Buy	+58,673	New	+$1.38M	0.01%	1411
2018 Q3	–	Sell	-6,054	Closed	-$222K	–	2297
2018 Q2	$222K	Buy	+6,054	New	+$197K	﹤0.01%	1987

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Man Group's MDCO Position: Q1 2020 in Review

Man Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 184,508 shares — an estimated $15.7M sold.

Man Group first reported a position in MDCO in Q2 2018 and held it in 3 quarters. The position peaked at $15.7M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Man Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Man Group sold 184,508 Medicines Co shares in Q1 2020, an estimated $15.7M.
Man Group first reported a position in Medicines Co in Q2 2018 and held it in 3 quarters.
Man Group's Medicines Co position peaked at $15.7M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Man Group's 13F filing for Q1 2020, filed 15 May 2020.